News | August 13, 2025
Apollo Hospitals Q1 FY26 PAT up 42% to Rs. 433 Cr
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Reinforcing commitment to ethical and sustainable growth
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Extended lab space for product development, customer demos, and training
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Ranks among the top 15% companies globally
Subscribe To Our Newsletter & Stay Updated
